Patrick Coyne to Treatment Outcome
This is a "connection" page, showing publications Patrick Coyne has written about Treatment Outcome.
Connection Strength
0.181
-
A trial of Scrambler therapy in the treatment of cancer pain syndromes and chronic chemotherapy-induced peripheral neuropathy. J Pain Palliat Care Pharmacother. 2013 Dec; 27(4):359-64.
Score: 0.049
-
Pain management, including intrathecal pumps. Curr Oncol Rep. 2004 Jul; 6(4):291-6.
Score: 0.026
-
Cognitive-behavioral therapy: tailored to the individual. Nurs Clin North Am. 2003 Sep; 38(3):465-76, vi.
Score: 0.024
-
How to use implantable intrathecal drug delivery systems for refractory cancer pain. J Support Oncol. 2003 May-Jun; 1(1):73-6.
Score: 0.024
-
Decreased low back pain intensity and differential gene expression following Calmare?: results from a double-blinded randomized sham-controlled study. Res Nurs Health. 2015 Feb; 38(1):29-38.
Score: 0.013
-
A randomized trial of the effectiveness of topical "ABH Gel" (Ativan(?), Benadryl(?), Haldol(?)) vs. placebo in cancer patients with nausea. J Pain Symptom Manage. 2014 Nov; 48(5):797-803.
Score: 0.013
-
A case of inaccurate prognostication after the ARCTIC protocol. J Pain Symptom Manage. 2012 Jun; 43(6):1120-5.
Score: 0.011
-
A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders. J Pain Palliat Care Pharmacother. 2012 Jun; 26(2):111-4.
Score: 0.011
-
Pilot trial of a patient-specific cutaneous electrostimulation device (MC5-A Calmare?) for chemotherapy-induced peripheral neuropathy. J Pain Symptom Manage. 2010 Dec; 40(6):883-91.
Score: 0.010